PSME3 and juvenile Huntington disease: Transgenic co-expression of Ku70 was effective for a Huntington's disease (HD) mouse model (R6/2 mice) (Enokido et al, 2010) but not effective for Atxn1-KI (Supplementary Fig S1H).